A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors

The COVID-19, caused by SARS-CoV-2, is threatening public health, and there is no effective treatment. In this study, we have implemented a multi-targeted anti-viral drug design strategy to discover highly potent SARS-CoV-2 inhibitors, which simultaneously act on the host ribosome, viral RNA as well...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Acta Pharmacol Sin
Autores principales: Ren, Peng-xuan, Shang, Wei-juan, Yin, Wan-chao, Ge, Huan, Wang, Lin, Zhang, Xiang-lei, Li, Bing-qian, Li, Hong-lin, Xu, Ye-chun, Xu, Eric H., Jiang, Hua-liang, Zhu, Li-li, Zhang, Lei-ke, Bai, Fang
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Singapore 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8076879/
https://ncbi.nlm.nih.gov/pubmed/33907306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-021-00668-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares